XTLBNasdaq Israel
Market cap
$7.225 M
$2.94 +2.44%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
—
Not reported
Shares outstanding
946,243,356
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Xtl Biopharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.